Citadel Advisors
IMCC

Citadel Advisors’s IM Cannabis IMCC Stock Holding History

Citadel Advisors’s Portfolio IMCC Stock Details IMCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-340
Closed -$68K – 14054
2021
Q4 		$68K Buy
+340
New +$66.3K ﹤0.01% 13050

Other funds holding IMCC

YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
HCWM
Hidden Cove Wealth Management Bainbridge Island, Washington $182M AUM 24.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's IMCC Position: Q3 2025 in Review

Citadel Advisors sold out of IM Cannabis (IMCC) in Q3 2025, closing a stake of 12,246 shares — an estimated $30.4K sold.

Citadel Advisors first reported a position in IMCC in Q4 2021 and held it in 8 quarters. The position peaked at $40K in Q4 2021. 15 funds tracked by Wall St. Rank hold IMCC as of Q3 2025.

  • Citadel Advisors reported no remaining IM Cannabis position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 12,246 IM Cannabis shares in Q3 2025, an estimated $30.4K.
  • Citadel Advisors first reported a position in IM Cannabis in Q4 2021 and held it in 8 quarters.
  • Citadel Advisors's IM Cannabis position peaked at $40K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held IM Cannabis as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.